Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors

Completed · Phase 2

Conditions studied: Muscle Pain, Joint Pain

In brief

The Purpose of this study is to determine whether vitamin D3 supplements will decrease the muscle and bone pain that are reported by women who take Aromatase Inhibitors.

Key facts

Study ID

NCT01509079

Run by

HealthPartners Institute

People needed

116

Starts

2012-03-01

Expected to finish

2015-03-01

Last updated by the study team

2019-06-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Women with a history of stage I-IIIa invasive breast cancer
• History of hormone-receptor positive cancer (either ER + or PR + or both)
• Are prescribed and are taking anastrozole, letrozole or exemestane for at least one month and have at least 7 months of AI treatment remaining
• Are experiencing AIMSS

You may not qualify if…

• Unable to read or understand English
• History of psychiatric disability affecting informed consent or compliance with drug intake
• Malabsorption syndrome or inability to take oral medication
• Has less than 7 months of AI therapy remaining

Where it is running

• Park Nicollet Frauenshuh Cancer Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.